Cam Gallagher - 06 Jul 2021 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Cam S. Gallagher
Issuer symbol
ZNTL
Transactions as of
06 Jul 2021
Net transactions value
-$861,856
Form type
4
Filing time
08 Jul 2021, 16:55:52 UTC
Previous filing
06 Jul 2021
Next filing
03 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale $130,804 -2,796 -0.55% $46.78 502,777 06 Jul 2021 Direct F1, F2
transaction ZNTL Common Stock Sale $36,271 -769 -0.15% $47.17 502,008 06 Jul 2021 Direct F1, F3
transaction ZNTL Common Stock Sale $2,637 -54 -0.01% $48.83 501,954 06 Jul 2021 Direct F1, F4
transaction ZNTL Common Stock Sale $30,596 -664 -0.13% $46.08 501,290 07 Jul 2021 Direct F1, F5
transaction ZNTL Common Stock Sale $49,644 -1,050 -0.21% $47.28 500,240 07 Jul 2021 Direct F1, F6
transaction ZNTL Common Stock Sale $40,980 -858 -0.17% $47.76 499,382 07 Jul 2021 Direct F1, F7
transaction ZNTL Common Stock Sale $551,133 -11,764 -2.4% $46.85 487,618 06 Jul 2021 Direct F8, F9
transaction ZNTL Common Stock Sale $14,894 -315 -0.06% $47.28 487,303 06 Jul 2021 Direct F8, F10
transaction ZNTL Common Stock Sale $4,896 -100 -0.02% $48.96 487,203 06 Jul 2021 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $46.08 to $47.06. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $47.08 to $48.07. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $48.11 to $49.01. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $45.52 to $46.50. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $46.55 to $47.54. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $47.56 to $48.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F9 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $46.23 to $47.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $47.26 to $47.49. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.